Valuation: MiniMed Group, Inc.

Market Cap 5.33B 4.63B 4.32B 3.97B 7.5B 507B 7.58B 50.9B 19.9B 254B 20.03B 19.59B 840B P/E 2027 *
28.8x
P/E 2028 * 27.9x
Enterprise Value 4.94B 4.29B 4B 3.67B 6.95B 470B 7.03B 47.16B 18.43B 235B 18.55B 18.15B 778B EV / Sales 2027 *
1.44x
EV / Sales 2028 * 1.28x
Free-Float
9.26%
Yield 2027 *
-
Yield 2028 * -
1 day-0.58%
1 week+7.65%
Current month+5.21%
1 month+21.81%
3 months+59.98%
1 week 17.66
Extreme 17.66
19.25
1 month 14.7
Extreme 14.7
19.25
Current year 10.65
Extreme 10.65
20.48
1 year 10.65
Extreme 10.65
20.48
3 years 10.65
Extreme 10.65
20.48
5 years 10.65
Extreme 10.65
20.48
10 years 10.65
Extreme 10.65
20.48
Date Insider Type Main position Quantity % Market Cap.
7/28/26 Tax

Chief Financial Officer

-23,301 0.0083%
7/28/26 Tax

Head of Human Resources

-2,099 0.0007%
7/1/26 Free

General Counsel

82,787 0.0295%
Change 5-day change 1-year change 3-year change Capi.($)
-0.58%+7.65% - - 5.33B
+0.37%+1.32%+34.87%+28.48% 12.77B
-0.79%0.00%+23.75%+23.18% 6.84B
+1.17%-1.68%+53.11%+26.30% 6.06B
-2.19%+1.40%-23.23%+39.88% 4.52B
-1.24%+3.38%-20.99%-18.35% 4.11B
-0.17%+0.68%-11.61%+204.62% 1.77B
+6.20%-0.25%+38.35%-43.01% 1.89B
+1.78%+5.78%+62.79%-2.17% 1.63B
+0.23%+5.93%-30.55%-49.27% 1.28B
Average +0.48%+1.73%+14.06%+23.29% 4.62B
Weighted average by Cap. +0.06%+1.76%+20.89%+24.45%

Financials

2027 *2028 *
Net sales 3.42B 2.97B 2.77B 2.54B 4.81B 325B 4.87B 32.66B 12.77B 163B 12.85B 12.57B 539B 3.7B 3.21B 3B 2.75B 5.21B 352B 5.26B 35.32B 13.81B 176B 13.9B 13.59B 583B
Net income 176M 153M 143M 131M 248M 16.74B 250M 1.68B 657M 8.37B 661M 647M 27.73B 207M 180M 168M 154M 291M 19.7B 294M 1.98B 773M 9.85B 778M 761M 32.63B
Net Debt -393M -341M -318M -292M -552M -37.35B -558M -3.75B -1.47B -18.67B -1.47B -1.44B -61.86B -601M -522M -486M -447M -845M -57.14B -854M -5.73B -2.24B -28.56B -2.26B -2.21B -94.64B
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-08-04 US$18.99 -0.58% 1,045,013
26-08-03 US$19.10 +5.82% 921,664
26-07-31 US$18.05 -0.52% 613,429
26-07-30 US$18.15 -1.39% 825,076
26-07-29 US$18.40 +4.31% 1,636,072
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
18.99USD
Average target price
21.00USD
Spread / Average Target
+10.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMED Stock